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Verapamil is used clinically as a Ca2+ channel inhibitor for the treatment of various disorders such as angina, hypertension and cardiac arrhythmia.
Here we study the effect of verapamil on the bacterium Escherichia coli. The drug was shown to inhibit cell division at growth sub inhibitory
concentrations, independently of the SOS response. We show verapamil is a membrane active drug, with similar effects to dibucaine, a local anesthetic.
Thus, both verapamil and dibucaine abolish the proton motive force and decrease the intracellular ATP concentration. This is accompanied by induction
of degP expression, as a result of the activation of the RpoE (SigmaE) extra-cytoplasmic stress response, and activation of the psp operon. Such effects of
verapamil, as a membrane active compound, could explain its general toxicity in eukaryotic cells.
© 2006 Elsevier B.V. All rights reserved.Keywords: E. coli; Verapamil; Dibucaine; DegP; Membrane potential; PspA1. Introduction
Ca2+ channel inhibitors have been used extensively, both clin-
ically and in research in eukaryote systems, in order to elucidate
the role of Ca2+ channels and their mode of action. Verapamil (a
phenyl alkylamine) is a specific inhibitor of eukaryotic voltage-
gatedL-type calciumchannels and is used in the range10–20μmolar
in the treatment of various disorders such as angina, hypertension
and cardiac arrhythmia [1]. It is generally believed that verapamil
blocks the flow of Ca2+ ions through the channel by binding to a
specific site on the internal face at the cytoplasmic end of the
channel. The positively charged verapamil (at physiological pH)
may interact with a putative Ca2+ binding site (negatively charged)
and in this way block the flow of Ca2+ ions [2,3]. However,
verapamil has also other effects in addition to the inhibition of
Ca2+ channels. For example, at 50 μM, verapamil competitively
inhibits the function of P-glycoprotein in mammalian cells [4].
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doi:10.1016/j.bbamem.2006.05.022pressed in multidrug-resistant (MDR) cells, is responsible for
ATP driven efflux of structurally unrelated cytotoxic drugs, and
thus, gives rise to resistance to many chemotherapeutic drugs in
cancer cells (see [5]). In this context, verapamil has been used as
a chemosensitizing agent to improve the clinical efficacy of anti
cancer therapy [6]. Similarly, verapamil can decrease the re-
sistance to anti-helminths drugs of parasitic helminths over-
expressing P-glycoprotein [7]. Verapamil was also found in vitro
to have a synergistic effect with itraconazole against clinical
isolates of Aspergillus fumigatus [8]. However, the use of vera-
pamil is limited by its general toxicity and it is important to better
understand the various pharmacological effects of this clinically
important drug.
Verapamil is an amphipath, i.e., it contains both hydrophilic
and hydrophobic groups. In addition, it contains a tertiary amine
which is protonated at physiological pH. The same chemical
characteristics exist in some local anesthetics. These molecules
can partition into the phospholipid bilayer of the membrane,
with their hydrophobic portion intercalating between the fatty
acyl chains, while the cationic groups may interact with the
negatively charged head groups of particular acidic phospholi-
pids [9]. These drugs appear to physically reorganize the lipid
bilayer, such that their accumulation in the membrane increase
its fluidity as well as affecting the ratio of bilayer to non-bilayer
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properties of the membrane, increasing membrane permeability
[13,14]. Importantly, the functioning of membrane proteins,
including different sensors and the activity of embedded en-
zymes, is likely to be influenced by membrane changes induced
by such drugs.
Previously, we have reported that N43, an E. coli strain
lacking the multidrug resistance AcrAB pump [15], is
hypersensitive to Ca2+ channel blockers, including verapamil,
suggesting that the drug might be a substrate of this pump [16].
Specific targets for verapamil action in E. coli have not,
however, been identified and an objective of this study was to
elucidate in more detail the effects of the drug. We found that
verapamil acted in a similar way to dibucaine and induced both
the RpoE mediated extracytoplasmic stress response and to
some extent the phage-shock response (PSP).
2. Materials and methods
2.1. Bacterial strains, media and chemicals
All bacterial strains in this study were derivatives of Escherichia coli K12.
Strain N43 ( F−, acrA1,Δlac-85, ara-14, galK12, rpsL179, malA1, xyl-5, mtl-1,
sup44 ) was described by Nakamura and Suganuma [17]. This strain has an IS2
element inserted in the acrA gene, which is polar on the downstream gene acrB
[18]. A degP::kan allele (from KS474, a gift from Jon Beckwith) and a cpxR::
spc allele (from PND325, a gift from T. Silhavy) were introduced into N43 by
P1 transduction according to Miller [19]. CAG16037 (araD,Δ(ara-leu)7697,Δ
(codB-lacI), galK16, galE15, mcrA0, relA1, rpsL150, spoT1, mcrB9999, hsdR2,
rpoHP3::lacZ) was from Carol Gross [20]. MC3 (F-araD139 ΔU169 rpsL150
relA1 flbB5301 deoC7 ptsF25 rbsR λΦ(pspA-lacZYA) is described in Bergler
[21] and PND2000 (F-lacΔU169 araD139 rpsL150 thi-flbB5301 deoC7 ptsF25
relA1 λ RS88 [degP::lacZ ]) is described in Danese et al. [22].
Luria–Bertini (LB) broth was prepared as in Miller et al. [19] and M63
minimal medium as described in Laoudj et al. [23]. When necessary, the medium
was supplemented with kanamycin (25 μg/ml), or spectinomycin (50 μg/ml).
Cells were grown at 30°C with continuous shaking, and cell mass was
monitored by measuring the absorbance at 600 nm (A600) using a Hitachi U-1100
spectrophotometer.
Radioactivity and protein standardswere purchased fromAmersham Interna-
tional, UK Ltd. Different drugs were purchased from Sigma Chemicals Ltd.,
while most other organic or inorganic compounds were purchased from either
Sigma Chemicals Ltd. or Merck Chemicals Ltd.
2.2. Protein labeling with 35S-methionine, preparation of heat stable
protein fraction and protein analysis
Cultures were grown in M63 minimal medium supplemented with 0.5%
(w/v) glucose at 30 °C. When the cell density reached an A600=0.2, drug was
added to the culture, which was incubated for 10 min before labeling with
10 μCi/ml of 35S-methionine for 10 min.
The heat stable protein fraction was prepared as follows. Cells were
harvested, resuspended in TEK buffer (100 mM KCl, 50 mM Tris–HCl pH 8,
1 mM EDTA), lysed by heating at 100 °C for 10 min and centrifuged at
13000 rpm for 15 min at 4 °C. The supernatant, containing the heat-stable
proteins, was transferred to a new tube and proteins precipitated by 5% TCA on
ice for at least 30 min; precipitates were collected by centrifugation at 13000 rpm
for 10 min, washed once with acetone and dried. Then the protein residue was
resuspended in SDS-sample buffer (0.125 mMTris–HCl (pH 6.8), 10% (w/v) β-
mercaptoethanol, 4% (w/v) SDS, 20% (w/v) glycerol, 0.05% (w/v) Bromophenol
blue) and boiled for 3 min prior to loading on gels for SDS-PAGE. SDS-PAGE
was carried out according to the method of Laemmli [24]. The separating gels
were 15% acrylamide with a stacking gel of 5%. Gels were fixed, dried and
autoradiographed against an X-ray film until a suitable exposure was obtained.2.3. ATP measurement
N43 was grown in M63 at 30 °C. At an A600=0.16, the culture was treated
with different concentrations of verapamil for 20 min. The cultures were kept on
ice until ATP measurements. ATP measurements were carried out essentially
according to the method described by Collura and Letellier [25]. 20 μl of culture
was added to 80 μl dimethylsulfoxide (DMS0) to destroy the cell envelope. The
lysed samples were diluted with 5 ml of cold sterile milliQ water to prevent any
interference of DMSO in the luminescence assay. 100 ml of this suspension were
withdrawn for ATP measurement with a luminometer (Lumac), using the
luciferin/luciferase assay system.
2.4. Measurement of membrane potential (ΔΨ)
The method was essentially according to Collura and Letellier [25]. A culture
of N43 was grown as usual in M63 at 30 °C to an A600=0.2, when 200 ml of cells
were harvested. The cells were permeabilised in 20ml Tris–EDTAbuffer (120mM
Tris–HCl pH 8, 1 mMEDTA) at 37 °C for 10 min with occasional agitation. After
centrifugation, the cells were washed in 20 ml HEPES/NaCl buffer (10 mM
HEPES, 150 mM NaCl, pH 7.2), recentrifuged and resuspended in 5.4 ml of the
same buffer and kept on ice until assayed.
270 μl of permeabilised cells were transferred to Eppendorf tubes and ener-
gized by the addition of 0.5% glucose and 0.6 mM KCl to restore the intracellular
concentration of K+. Different concentrations of the drugs to be tested were added
and the samples incubated for 10 min at 30 °C. A mixture of non and radioactive
3H-TPP (tetraphenylphosphonium ion, 10mM, 25μCi) was added and the samples
were further incubated for 10 min at 30 °C. 100 μl (equivalent to 2×108 cells) of
samples were filtered in triplicate on GF/C membranes and quickly rinsed twice
with 5 ml HEPES/NaCl buffer. Filters were dried, transferred to scintillation vials,
and scintillation liquid added. The radioactivity on the filters was countedwit a pre-
set 3H/14C program. TPP+ uptake valueswere corrected for non-specific binding by
subtracting the counts obtained for cells treated with 20 μMCCCP under the same
conditions as above.
The membrane potential was calculated using Nernst's equation:
DΨ ¼ 2:3RT=F logðVout=Vin  ½TPPin=½TPPout
(For E. coli: Vout/Vin=1000 for a suspension of 2×10
9 cells/ml. At 30 °C:
2.3 RT/F=60 mV).
2.5. Western blotting
Total cell proteins (equal A600 loadings) were separated by SDS-PAGE
(15%) and transferred onto nitrocellulose membranes (Schleicher and Schull,
0.45 μM) by electroblotting, at 4 °C, for 45 min at 70 V in 25 mM Tris, 192 mM
glycine, 20% (v/v) methanol, pH 8.3. Subsequent steps were carried out at room
temperature. Proteins were fixed to the membrane by 0.025% glutaraldehyde for
40 min. Non-specific sites were blocked in 5% non-fat milk powder in PBS
(prepared as described in [26]) for 3 h. Thereafter, the membrane was incubated
overnight with primary antibody (1/1000 in PBS-buffer containing 0.5% non-fat
milk) with gentle shaking. After 4 washings in PBS buffer, the membrane was
incubated with the secondary antibody (anti-rabbit antibody conjugated to
peroxidase) at a dilution of 1/10000 in PBS for 1 h. Cells were washed twice in
PBS before detection by enhanced chemiluminescence (ECL), according to the
manufacturer's (Amersham) instructions.
2.6. β-galactosidase assays
σE activitywas assayed bymonitoringβ-galactosidase activity expressed from
the chromosomal σE dependent lacZ reporter gene rpoHp3-lacZ [20]. Enzymatic
activity was measured as described in Miller [19] and expressed in Miller Units.
3. Results
3.1. Effect of verapamil upon E. coli growth
Previous results showed that strain N43, an acrA1 mutant of
E. coliK12, which carries an IS2 insertion interrupting the acrAB
operon (see also Materials and methods) is hypersensitive to
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and diltiazem) and to inhibitors of calmodulin (W7, 48/80, TFP),
indicating that these drugs are probably substrates of the major
multidrug resistance pump encoded by the acrAB genes [15,16].
TheMIC of verapamil for the N43 strainwas found to be 0.3mM,
a 10-fold reduction in the MIC for a wild-type E. coli K12 strain.
We took advantage of this hypersensitivity of the acrA1
mutant to study the effect of verapamil on E. coli growth and
physiology. Previous microscopic studies [27] indicated that a
low concentration of verapamil inhibited cell division in N43. In
this study we sought to confirm this effect using flow cytometry.
Strain N43 was grown in minimal medium to early exponential
phase, as described in Materials and methods, and treated with
increasing concentrations of verapamil. At 300 μM verapamil, as
shown in Fig. 1A, growth was inhibited after 2 to 3 generations (3
to 5 h). As shown in Fig. 1B, this inhibition could be reversed by
the addition ofMg2+ or Ca+2. Since this effect was not specific for
Ca2+, we hypothesized that the addition of these divalent cations
contributes to a generally decreased permeability of the outer
membrane to the drug. This result also indicated that the effect is
reversible and hence that the drug is bacteriostatic rather than
bacteriocidal. Determination of viable counts for verapamil-
treated cultures confirmed that the drug is bacteriostatic, not
bacteriocidal, at least up to 0.5 mM (data not shown).
At a lower concentration (200 μM), verapamil had little if any
effect on growth (Fig. 1A). However, microscope analysis indi-
cated that this concentration of drug resulted in a heterogeneous
cell size distribution with many cells 2–4 times normal length.
This effect on cell division, giving a heterogeneous size dis-
tribution, was confirmed by flow cytometry (Fig. 1C). In order to
determine whether the effect of verapamil on cell division was
due to induction of the SOS response, the effect of the drug on
DNA synthesis was measured. At concentrations (150–200 μM)
affecting cell division, the drug had no detectable effects on DNA
synthesis. Moreover, no increase in the level of the RecA protein
(measured by Western blot, or using a sfiA-lacz fusion) could be
detected in verapamil-treated cells (all data not shown). Thus,
verapamil treatment results in division inhibition by a mechanism
independent of the SOS response at concentrations which are
below those required for growth inhibition. Thismechanismmight
include effects on the cytoplasmic membrane that perturb the
action of the division machinery in some way. Possible ways in
which verapamil could affect the membrane are explored below.
3.2. Verapamil induces a specific set of heat-stable proteins
We have previously shown [23] that treatment of E. coli N43
with the Ca2+ chelator EGTA, induces the synthesis of a specific
family of heat-stable, low molecular weight acidic proteins, with
apparent molecular weights of 12, 14.3, 17, 18, 21.5–23, 27, 34–
35 kDa. These include three potential Ca2+ binding proteins, P34,
P18 andP12 (named from their apparentmolecularweight in SDS-
PAGE), since they cross-reactedwith antibodies to calmodulin and
to the calmodulin-like protein calerythrin from Saccharopoly-
spora erythraea. We hypothesized that some or all of these
proteins belong to a putative Ca2+ regulon and were induced in
response to perturbation of intracellular Ca2+ homeostasis by theEGTA treatment. Verapamil is a Ca2+ channel blocker in eukar-
yotic cells, and it was interesting to test whether in bacteria, it could
also disturb Ca2+ homeostasis and induce a similar set of proteins.
The results, shown Fig. 2, indicate that verapamil, at a minimal
concentration of 500 μM, specifically induced the synthesis of
three major heat-stable polypeptides with apparent molecular
weight corresponding to 14 kDa (P14), 17 kDa (P17) and 50 kDa
(P50). Qualitatively, this profile, which was highly reproducible,
is very different from that obtained after induction by EGTA [23]
although the 14 kDa and 17 kDa had similar molecular weights to
two proteins induced by EGTA. However, further analysis using
2-D gels showed that P14 and P17, induced by verapamil,
migrated towards the basic end of the gel (data not shown) and
were clearly different from the two heat-stable, acidic proteins
identified previously [23].
3.3. P50 is identical to DegP, the periplasmic serine protease
Verapamil is an amphipathic drug also containing a tertiary
amine group protonated at physiological pH and, as such, presents
some characteristics similar to that of local anesthetics for exam-
ple dibucaine, and can therefore be expected to disturb the mem-
brane bilayer. It is now well established in bacteria that damage to
the cell membrane or components of the cell envelope in general,
triggers protective responses to such stress and we anticipated
therefore that verapamilmight generate such an extra-cytoplasmic
stress [28,29]. In E. coli, there are two main pathways which
control the response to such stress, the two-component cpxA/cpxR
system and the extracytoplasmic stress response, that is mediated
by the alternative sigma factor RpoE. DegP is a periplasmic
protease of 48 kDa, whose synthesis is controlled by both
pathways and therefore a possible candidate for P50. To test this,
cells were treated with verapamil for 60min and total cell proteins
were separated by SDS-PAGE, followed by Western blotting
using anti-DegP antibodies. The results shown in Fig. 3 clearly
demonstrated that the amount of DegP is substantially increased
in the presence of the drug. Moreover, when a N43degP::kan
strain, which grows quite normally, was treated by verapamil,
expression of P14, P17 but not P50 was induced, consistent with
P50 being DegP (data not shown).
3.4. Induction of DegP is independent of the cpxA/R pathway
Expression of degP is under the control of two pathways, the
two-component cpx pathway [30] responding to surface attach-
ment or alkaline pH [31] and the rseA/rpoE pathway [32], re-
sponding to accumulation of misfolded outer membrane proteins
in the periplasm [20]. E. coli strains lacking CpxA (the sensor) or
CpxR (the response regulator) fail to induce degP expression,
following overproduction of NlpE, a known inducing signal of
the pathway [30]. To test whether induction of DegP by verapamil
was dependent upon the cpxA/R system, a cpxR mutant was
analyzed for induction of [35S]-labeled DegP, P14 and P17
proteins by verapamil, as before. The results (Fig. 4) clearly
showed that verapamil induction of P14, P17 andDegP, optimal at
0.5 mM verapamil, was not affected in the cpxR mutant. This
indicated that the CpxA/R pathway is not induced by verapamil.
Fig. 1. (A) Effect of verapamil on growth of E. coli. A culture of N43 was grown in M63 minimal medium at 30° and at A600=0.15 was treated with different
concentrations of verapamil as follows: open diamonds: 0 mM; open squares: 0.2 mM; open circles: 0.3 mM; open triangles: 0.4 mM, closed squares: 0.5 mM; closed
circles: 1 mM. Growth was followed by optical density measurement as described in Materials and methods. (B) Ca2+ or Mg2+ reverse the growth inhibition of
verapamil. N43 was grown in M63 minimal medium at 30 °C and at A600=0.15, the cells were treated with 0, (squares) ; 0.3 (diamonds) or 0.5 mM (circles) verapamil.
After 2 h of treatment, respectively 10 mM CaCl2 (black symbols) or MgCl2 (gray symbols) was added. Growth was followed by measurement of optical density.
(C) The effect of verapamil on cell division of N43 analyzed by flow cytometry. N43 was grown in M63 minimal medium at 30 °C. At early exponential phase
(A600=0.05), 0 (left panel) or 0.15 mM (right panel) verapamil, was added to the culture. After 4 h growth, aliquots of culture were taken and prepared for flow
cytometry and analyzed as described in Materials and methods.
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Since DegP induction by verapamil was independent of the
cpxA/R two-component pathway, we surmised that its induction
was due to activation of the RpoE pathway by verapamil. In theabsence of stress, RpoE is normally sequestered to the membrane
by the inner membrane-localized anti-sigma factor RseA. Extra-
cytoplasmic stress, resulting from accumulation of outer mem-
brane proteins in the periplasm, leads to the activation of a
proteolytic cascade. Thus, the essential periplasmic proteaseDegS,
followed by the action of the cytoplasmic membrane protease
Fig. 4. The effect of a cpxR mutation on the induction of P14, P17 or DegP
synthesis by verapamil. The radio-labeled heat stable proteins of cells from
cultures of the parental strain N43 and its cpxR derivative treated with vera-
pamil at the indicated concentration, as described in Fig. 2, were analyzed
by SDS-PAGE.
Fig. 2. Effect of verapamil on the synthesis of heat stable proteins in mid
exponential phase cultures. N43 was grown exponentially in M63 minimal
medium at 30 °C. At an A600=0.2, verapamil was added to N43 at various
concentration. After 10 min of treatment the cells were radio-labeled with 35S-
methionine for 10 min. The samples were then processed as described in Materials
and methods for preparation of the heat stable protein fraction before analysis by
SDS-PAGE (15% acrylamide). Identical A600 equivalent of cells were loaded on
each track. An autoradiogram of the fixed, dried gel is shown. The proteins P14,
P17, and P50 most clearly induced by the drug are indicated by arrows.
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triggering expression of the RpoE regulon [33].
Since an rpoE deletion mutation is lethal [34], in order to
check whether verapamil activated the RpoE response, we used a
lacZ transcriptional fusion, where lacZ was fused to the rpoHp3
promoter. This promoter is uniquely dependent for its transcrip-
tion upon RpoE. As shown in Fig. 5, verapamil significantly (3-
fold at 3 mM) increased expression from this promoter, conf-
irming that it could induce the extra-cytoplasmic stress response
mediated by RpoE. Note that in this experiment, the range of
verapamil concentrations employedwas higher than in the case of
N43, since the strain used is AcrAB+ and hence more resistant to
verapamil than N43 (the MICs being 3 mM for an AcrAB+ strain
versus 0.3 mM for an acrAB mutant).
3.6. Comparison of the action of verapamil and dibucaine
In order to approach the question of how verapamil might
provoke these changes in gene expression, its effect on the syn-Fig. 3. Induction of DegP by verapamil treatment. A culture of N43 was grown
in M63 at 30 °C, and at an A600=0.2, the culture was treated with different
concentrations of verapamil for 60 min (indicated below) and samples of total
proteins were prepared. Equal amounts of protein (A600 equivalent of cells) were
loaded onto an acrylamide gel and after separation by SDS-PAGE electro-
blotted onto a nitrocellulose membrane. The Western blot was carried out as
described in Materials and methods, using polyclonal anti-DegP antibody.thesis of heat-stable polypeptides analyzed by SDS-PAGE, was
compared with the action of a number of different drugs (ceru-
lenin, CCCP, nalidixic acid, novobiocin, rifampicin, chloram-
phenicol, tetracycline and the membrane active drug dibucaine).
Only dibucaine treated cells displayed a similar pattern of induc-
tion to that shown by verapamil treated cells (Fig. 6 and data not
shown). Dibucaine is a local anesthetic, a category of amphipathic
drugs that affect the ratio of bilayer to non-bilayer structures in the
membrane and increase membrane fluidity. Our results suggested
therefore that verapamil in bacteria could act in a similar way toFig. 5. Induction of RpoE activity by verapamil. CAG16037 (rpoHp3-lacZ acrA
+)
was grown in LB until A600=0.3. Verapamil was then added at increasing
concentrations (0, 0.5, 1, 2, 3 mM). After 30 min, samples were withdrawn and
β-galactosidase activity was assayed as described in Materials and methods.
Fig. 6. Verapamil and dibucaine have similar effects upon the synthesis of heat-
stable proteins. An exponentially growing culture of N43 at 30 °C (A600=0.2)
was mixed with different concentrations of verapamil or dibucaine and after
10 min of treatment radio labeled with 35S-methionine for a further 10 min. The
samples were processed as described in Materials and methods for preparation
of the heat-stable protein fraction before analysis by 15% SDS-PAGE. An
autoradiogram of the dried gel is shown. The positions of P14, P17 and DegP are
indicated by arrows on the right.
Fig. 7. Effect of verapamil on the internal ATP concentration (A) and on the
transmembrane electrical potential (ΔΨ ) of N34 cells (B). The level of ATP was
measured after 20 min treatment with different concentrations of verapamil as
described in Materials and methods. ΔΨ was measured in EDTA-permeabilised
cells using 3H-TPP+ as a radioactive probe, also as described in Materials and
methods The drug was added 10 min prior to the addition of TPP+.
Fig. 8. Both verapamil and dibucaine induce the synthesis of the phage shock
protein PspA. Samples of total proteins of N43 cells treated with either
verapamil or dibucaine for 60 min, were analyzed by Western blotting using
PspA polyclonal antibodies.
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3.7. Verapamil and dibucaine affect the membrane electrical
potential and induce the synthesis of PspA
Previous studies [25] showed that dibucaine treatment of
E. coli, led to an increase in ATP levels at low drug concentra-
tions, while higher concentrations (>500 μM) led to a substantial
reduction in internal ATP levels. They also showed that dibucaine
had a marked effect on the membrane electrical potential (ΔΨ ),
that is, enhancing at low concentrations, inhibiting at high con-
centrations. As shown in Fig. 7, verapamil also behaves in the
same way with respect to ATP levels and the membrane electrical
potential.
PspA (phage shock induced protein) is an inner membrane of
25.3 kDa, which is induced in response to envelope stress and
seems to play a role in the maintenance of the proton motive
force [35]. Accordingly, we investigated whether verapamil and
dibucaine could also induce the synthesis of this protein, as
detected by western blotting, using anti-PspA antibodies. As
shown in Fig. 8, when exponentially growing cells were treated
with low concentrations of verapamil or dibucaine for 30 min in
M63-medium at 30 °C, moderately enhanced synthesis of PspA
was observed. Note that unlike DegP, PspA is not heat-resistant
and total cell proteins, rather than the heat-resistant fraction, wereanalyzed in Fig. 8. PspA induction was detected at sub-inhibitory
concentrations of verapamil, as low as 50–100 μM, although
higher levels of PspAwere induced at 1.0 mM (data not shown).
Since verapamil induced the synthesis of PspA we consid-
ered the possibility that the products of pspB (9 kDa) and pspC
Fig. 9. Verapamil induces the synthesis of DegP and PspA in a wild type Acr+
strain. Strains MC3 ( pspA-lacZ ) and PND2000 (degP-lacZ ) were grown in LB
untilA600=0.4. Verapamil was then added at increasing concentrations (0, 0.5, 1, 2,
3 mM). After 30 min, samples were withdrawn and β-galactosidase activity was
assayed as described in Materials and methods.
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correspond to P14 and P17 induced by verapamil. However,
both these proteins, together with DegP, were still induced to the
normal high levels, when the pspB and pspC genes respectively
were disrupted (data not shown). PspC and PspB are normally
required for high-level synthesis of PspA. PspC is thought to be a
membrane sensor which may detect changes in the proton motive
force [35]. Since in the absence of PspC or PspB, P14 and P17 are
still induced to high levels, these proteins are not in any way co-
regulated with the products of the psp operon.
3.8. Verapamil induces the synthesis of DegP and PspA
independently of the presence of the acrA1 mutation
In this study we mostly used the N43 strain, which carries an
acrA1 mutation, in order to bypass the resistance to verapamil
due to the AcrAB pump, the main multidrug resistance pump in
E. coli. However, the fact that verapamil was able to induce the
RpoE mediated response in a wild-type background, albeit at a
10-fold higher concentration (Fig. 5) suggested that the effect of
verapamil was not dependent upon the specific N43 background.
To confirm this fact, we looked whether verapamil could induce
DegP and PspA in a wild-type, acrA+ strain, using degP-lacZ and
a pspA-lacZ reporter fusion strains. As shown in Fig. 9, treatment
of wild-type E. coli by increasing concentration of verapamil, in
the range used in the case of the RpoE response (0.5 to 3 mM) led
to the induction of DegP at concentrations of 1 mM and above.
PspA synthesis was also found to be induced, although to a less
extent than DegP and at 2 mM. Hence, those results confirm in a
wild-type background the results obtained in the N43 background
and show that the verapamil effect we describe in this study was
not due to an indirect effect on the cells of the acrA1 mutation.
4. Discussion
The utilization of strain N43 and its derivatives, all lacking a
functional AcrAB multidrug resistant pump [15,18], has enabledus to study the effects of this amphipathic drug in E. coli, in the
μM range. Although we have no direct evidence that verapamil is
a substrate for the AcrAB pump, in its absence the MIC for
verapamil in N43 is reduced 10-fold [16]. In the acrA strain,
inhibition of cell division is now detectable at sub-growth inhibi-
tory concentrations of drug and the synthesis of three proteins,
P14, P17 and P50 (DegP), is strongly induced, whilst this is not
observed in the wild type strains. This indicates that verapamil is
normally removed by the AcrAB pump reducing its accumulation
in the cytoplasmic membrane.
In this paper, we show that low concentrations of verapamil
(100–150 μM) reduced the frequency of cell division, producing
a heterogeneous population with cell sizes, 2–4 times that of
untreated cells. At these concentrations of drug, the synthesis of
DNA, RNA and protein was not detectably affected. The syn-
thesis of RecA protein was also not induced by verapamil treat-
ment (all data not shown) and therefore induction of the SDS-
response was not responsible for the inhibition of cell division.
However, in the light of the evidence discussed below, that ve-
rapamil likely perturbs the integrity of the membrane bilayer,
disruption of the assembly of the FtsZ complex at mid cell by
verapamil, is a possibility.
One reason to undertake this study was to explore the potential
role of Ca2+ in cell cycle regulation in bacteria, anticipating that
verapamil, as in eukaryotic cells, might inhibit potential Ca2+
channels. However, the effect of verapamil and EGTA [23] as
indicated by changes in gene expression, were quite different.
Moreover, studies directly measuring free Ca2+ levels in E. coli,
provided further evidence that verapamil does not affect Ca2+
levels. Thus, while EGTA treatment does reduce levels of free
intracellular Ca2+, as we have reported previously [37], verapamil
does not [38]. Although so far, we have no data on the identity of
the two heat-stable proteins, P14 and P17 induced by verapamil
treatment, wewere able to demonstrate that P50 is the periplasmic
protease DegP. degP expression has been shown to be regulated
by two different pathways, the two-component cpxA/R pathway
[22], that responds to a variety of envelope stresses and the RpoE
mediated response to extracytoplasmic stress. Verapamil induc-
tion of DegP synthesis (and P14 and P17 synthesis) was clearly
shown to be independent of cpxR. A direct test of the involvement
of RpoE in the synthesis of verapamil induced proteins, was not
possible since we found that strains lacking rpoEwere apparently
non viable (see also [34]). However, we were able to demonstrate
that verapamil could induce the expression of the RpoE-
dependent promoter rpoHp3-lacZ, clearly indicating that the
expression of degP also proceeds through the RpoE pathway. The
RpoE regulon comprises next to one hundred genes, with a great
number of those genes involved in the synthesis, assembly and
homeostasis of lipopolysaccharide and outer membrane proteins
in addition to a protein degrading enzyme likeDegP [39].We note
that the degPmutant is in fact nomore sensitive to verapamil than
its parental strain (data not shown), therefore other genes in the
regulon are normally important for verapamil resistance.
Amongst a wide variety of drugs tested in the course of this
work only the amphipaths, W7, diltiazem (data not shown) and
dibucaine, in addition to verapamil, induced the synthesis of P14,
P17 and DegP. All these compounds share the property of
1594 C.L. Andersen et al. / Biochimica et Biophysica Acta 1758 (2006) 1587–1595affecting the ratio of bilayer to non-bilayer structures in the
membrane and would be expected to increase membrane fluidity.
Irrespective of the precise pathway that facilitates verapamil
activation of RpoE, the drug-induced changes in fluidity are likely
to affect the activity of one or more membrane proteins.
Considering the effects of verapamil and local anesthetics on
membrane structure, we can envision two alternative mechanisms
to activate RpoE. The current model of activation of the RpoE
response is an accumulation of C-terminal domains of unfolded
proteins that triggers the activation of the periplasmic protease
DegS, the subsequent cleavage of RseA by DegS, and then by
YaeL/RseP, finally leading to activation of RpoE. Thus, a
mechanism for the action of verapamil could be an accumulation
of unfolded outer membrane proteins and/or an LPS defect, as a
consequence of perturbed transport through the inner membrane
or as a direct effect of verapamil on the outer membrane.
Alternatively, we cannot exclude that structural changes in the
inner membrane caused by verapamil (as well as by dibucaine)
might be sensed directly, leading to activation of RpoE by
mechanisms dependent or independent of RseA (see also [40]).
The effect of verapamil (this study) and dibucaine [25]
reducing both the electrical membrane potential and intracellular
ATP levels, could stem from inhibition of the ATP-synthase
complex, through bilayer changes. Indeed, recent studies with the
Lactococcus lactis OpuA (Glycine-betaine transporter) protein
reconstituted into membrane vesicles, have demonstrated that
both verapamil and a local anesthetic, tetracaine, dramatically
affect transport activity, apparently by accumulation of the drugs
in the inner leaflet of the bilayer (B. Poolman, personal commu-
nication; see also [41]). Alternatively, the decrease of ΔΨ itself
could be due to an increased passive flux of protons, following an
increase in membrane permeability, resulting from transient pore
formation, which has been proposed to accompany the action of
such membrane active drugs [13,14,42].
Whatever the precise mechanism, loss of membrane potential
following verapamil treatment, would be expected to induce the
phage-shock-protein operon (psp) involved in protection against
dissipation of the proton-motive force [35,36,43]. PspA synthesis
is also induced when other outer membrane proteins are over-
expressed, or in response to stress induced by uncouplers, ceru-
lenin, high temperature or by ethanol, some of which also induced
the RpoE dependent response [36]. A previous study [35] also
showed that the 26 kDa PspA protein, which is peripherally
bound to the cytoplasmic membrane, is implicated in maintaining
the proton motive force (PMF). Moreover, mutations affecting
ATP synthase were found to induce the psp operon both in Yer-
sinia enterocolitica and in E. coli [44]. Here we show that both
verapamil, and dibucaine, cause dissipation of the PMF, and
particularly dibucaine, induce expression of PspA, supporting the
hypothesis of a role for the PMF in induction of the psp operon.
However, the verapamil induced proteins P14 and P17 are ap-
parently not identical to PspC and PspB, and since the psp regulon
was determined recently to be limited to the pspABCDE operon
and the unlinked gene, pspG/yjbO, encoding a 9 kDa protein, P14
and P17 may therefore belong to the large RpoE regulon.
In summary, in this report we showed that treatment by
verapamil induced two extra-cytoplasmic stress responses, theRpoE and the Psp responses. In contrast, verapamil did not appear
to activate the cpxA/R mediated response. The action of verapa-
mil strongly resembles that of the local anesthetic, dibucaine.
Altogether, our results show that verapamil is a membrane active
drug, which could explain its toxicity in vivo. In addition, vera-
pamil, as well as anesthetics such as benzyl alcohol and ether,
have been found to abolish P-glycoprotein (Pgp) ATPase activity,
thus modulating efflux from multidrug-resistant cells [12]. Vera-
pamil is a competitive inhibitor of P-glycoprotein. However, the
results by Regev et al. [12] suggest an alternative, additional
mechanism for modulation of Pgp activity, that of an indirect
inhibition of Pgp activity through fluidization of the lipid phase of
the membrane. Our findings are in favor of such a potential mode
of action and are clearly relevant to the clinical use of verapamil.
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